Live search
TopFind is fetching the latest matches for your search.
We reviewed 100 live results for trastuzumab biosimilar and narrowed them down to the 3 options that look most worth comparing first.
The strongest themes across this short list are Oncology and Monoclonal Antibodies.
Source: Biocon Biologics Philippines Inc.
Description
A biosimilar monoclonal antibody for the treatment of HER2-positive breast and gastric cancers, available in the Philippines since 2018.
Best for
HER2 Positive breast cancer, Gastric cancer treatment and Oncology therapy
Rating
Source: Pfizer Philippines Inc.
Description
Trazimera is a monoclonal antibody biosimilar for the treatment of HER2-positive breast and stomach cancers, receiving PH FDA approval in 2022.
Best for
HER2 Positive breast cancer, Stomach cancer and Targeted oncology therapy
Rating
Source: Celltrion Healthcare Philippines Inc.
Description
Herzuma is a biosimilar used in the treatment of HER2-positive cancers, providing a high-quality alternative to reference biologics.
Best for
HER2 Positive cancer, Oncology therapy and Biosimilar oncology
Rating
| Compare | Trastuzumab Biosimilar | Trazimera (Trastuzumab) | Herzuma (Trastuzumab) |
|---|---|---|---|
| Source | Biocon Biologics Philippines Inc. | Pfizer Philippines Inc. | Celltrion Healthcare Philippines Inc. |
| Description | A biosimilar monoclonal antibody for the treatment of HER2-positive breast and gastric cancers, available in the Philippines since 2018. | Trazimera is a monoclonal antibody biosimilar for the treatment of HER2-positive breast and stomach cancers, receiving PH FDA approval in 2022. | Herzuma is a biosimilar used in the treatment of HER2-positive cancers, providing a high-quality alternative to reference biologics. |
| Best for | HER2 Positive breast cancer, Gastric cancer treatment and Oncology therapy | HER2 Positive breast cancer, Stomach cancer and Targeted oncology therapy | HER2 Positive cancer, Oncology therapy and Biosimilar oncology |
| Action | |||
| Rating |
If you want the most balanced option to start with, I recommend:
"Trastuzumab Biosimilar from Biocon Biologics Philippines Inc.."
I picked this because This biosimilar provides a targeted oncology treatment for HER2-positive cancers with a proven local track record.